Reference
Shapiro Ben David S, et al. Rate of Recurrent Guillain-Barre Syndrome After mRNA COVID-19 Vaccine BNT162b2. JAMA Neurology : 1 Sep 2021. Available from: URL: http://doi.org/10.1001/jamaneurol.2021.3287
Rights and permissions
About this article
Cite this article
Minimal risk of GBS relapse after Pfizer-BioNTech COVID-19 vaccination. Reactions Weekly 1873, 12 (2021). https://doi.org/10.1007/s40278-021-02435-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-021-02435-5